A randomized placebo-controlled phase Ia malaria vaccine trial of two virosome-formulated synthetic peptides [PEV-301, PEV-302; Pevion Biotech] in healthy adult volunteers
Phase of Trial: Phase I
Latest Information Update: 25 Jan 2011
At a glance
- Drugs Malaria vaccine (Primary)
- Indications Falciparum malaria
- Focus Adverse reactions; Pharmacodynamics
- 24 Mar 2009 Status reported as discontinued by ClinicalTrials.gov.
- 07 Dec 2006 New trial record.